Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by AmorFatiforlifeon Aug 18, 2020 11:04am
145 Views
Post# 31422667

RE:RE:RE:RE:RE:RE:RE:Market News & Research Alert from TD

RE:RE:RE:RE:RE:RE:RE:Market News & Research Alert from TDApologies for the format that my post came through. I find the interface for SH on a cellphone quite cumbersome and awkward. I am working full time so i check through my stock stuff periodically and don't have time to re read. You bring up some really interesting and valid points and theories. I've been in this company for about 4 years or so, and i have asked myself all of those questions that you've brought up. Ultimately none of us retail guys know the answers and we can only speculate. For myself a lot of the frustration lies in the valuation of EDT compared to other companies in the same field and the blatant, well obvious to most of the people who have been around this stock for a while, manipulation and lack of promoting or marketing. Perhaps your correct that the c suite is getting paid a handsome salary and they aren't thinking about retail investors, or the day to day fluctuations of the SP, but i personally have a time believing that in the corporate world with a BOD to answer to that a company can anti promote to this extent without an ulterior motive. I worked in Pharma for a number of years, and those companies don't just throw money at every little project with potential. I know 5 million, with more to come, is pennies to them but i also know that the decision for them to invest in r and d companies isn't just a roll of the dice. Im an optimist by nature and i believe in the science behind this company. In my opinion, based on the facts as you've brought them up, i personally believe that there is an end game to the 20 years of rock pounding as you so eloquently put it. Regards
<< Previous
Bullboard Posts
Next >>